These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33077712)

  • 1. Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancy.
    Wessel AW; Kose N; Bombardi RG; Roy V; Chantima W; Mongkolsapaya J; Edeling MA; Nelson CA; Bosch I; Alter G; Screaton GR; Fremont DH; Crowe JE; Diamond MS
    Nat Commun; 2020 Oct; 11(1):5278. PubMed ID: 33077712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal Antibodies against Zika Virus NS1 Protein Confer Protection via Fc
    Yu L; Liu X; Ye X; Su W; Zhang X; Deng W; Luo J; Xiang M; Guo W; Zhang S; Xu W; Yan Q; Wang Q; Cui Y; Wu C; Guo W; Niu X; Zhang F; Lei C; Qu L; Chen L; Feng L
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesicular Stomatitis Virus and DNA Vaccines Expressing Zika Virus Nonstructural Protein 1 Induce Substantial but Not Sterilizing Protection against Zika Virus Infection.
    Li A; Xue M; Attia Z; Yu J; Lu M; Shan C; Liang X; Gao TZ; Shi PY; Peeples ME; Boyaka PN; Liu SL; Li J
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32554698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Monoclonal Antibodies against NS1 Protein Protect against Lethal West Nile Virus Infection.
    Wessel AW; Doyle MP; Engdahl TB; Rodriguez J; Crowe JE; Diamond MS
    mBio; 2021 Oct; 12(5):e0244021. PubMed ID: 34634945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses to Zika virus proteins in pregnant and non-pregnant macaques.
    Heffron AS; Mohr EL; Baker D; Haj AK; Buechler CR; Bailey A; Dudley DM; Newman CM; Mohns MS; Koenig M; Breitbach ME; Rasheed M; Stewart LM; Eickhoff J; Pinapati RS; Beckman E; Li H; Patel J; Tan JC; O'Connor DH
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006903. PubMed ID: 30481182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies Elicited by an NS1-Based Vaccine Protect Mice against Zika Virus.
    Bailey MJ; Broecker F; Duehr J; Arumemi F; Krammer F; Palese P; Tan GS
    mBio; 2019 Apr; 10(2):. PubMed ID: 30940710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NS1 DNA vaccination protects against Zika infection through T cell-mediated immunity in immunocompetent mice.
    Grubor-Bauk B; Wijesundara DK; Masavuli M; Abbink P; Peterson RL; Prow NA; Larocca RA; Mekonnen ZA; Shrestha A; Eyre NS; Beard MR; Gummow J; Carr J; Robertson SA; Hayball JD; Barouch DH; Gowans EJ
    Sci Adv; 2019 Dec; 5(12):eaax2388. PubMed ID: 31844662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single-dose circular RNA vaccine prevents Zika virus infection without enhancing dengue severity in mice.
    Liu X; Li Z; Li X; Wu W; Jiang H; Zheng Y; Zhou J; Ye X; Lu J; Wang W; Yu L; Li Y; Qu L; Wang J; Li F; Chen L; Wu L; Feng L
    Nat Commun; 2024 Oct; 15(1):8932. PubMed ID: 39414822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZIKV-Specific NS1 Epitopes as Serological Markers of Acute Zika Virus Infection.
    Kam YW; Leite JA; Amrun SN; Lum FM; Yee WX; Bakar FA; Eng KE; Lye DC; Leo YS; Chong CY; Freitas ARR; Milanez GP; Proença-Modena JL; Rénia L; Costa FTM; Ng LFP;
    J Infect Dis; 2019 Jun; 220(2):203-212. PubMed ID: 30901054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein.
    Li A; Yu J; Lu M; Ma Y; Attia Z; Shan C; Xue M; Liang X; Craig K; Makadiya N; He JJ; Jennings R; Shi PY; Peeples ME; Liu SL; Boyaka PN; Li J
    Nat Commun; 2018 Aug; 9(1):3067. PubMed ID: 30076287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models.
    Li P; Ke X; Wang T; Tan Z; Luo D; Miao Y; Sun J; Zhang Y; Liu Y; Hu Q; Xu F; Wang H; Zheng Z
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient Control of Zika Virus Infection Induced by a Non-Replicating Adenovector Encoding Zika Virus NS1/NS2 Antigens Fused to the MHC Class II-Associated Invariant Chain.
    Nazerai L; Buus S; Stryhn A; Thomsen AR; Christensen JP
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zika Virus Non-Structural Protein 1 Antigen-Capture Immunoassay.
    Beddingfield BJ; Hartnett JN; Wilson RB; Kulakosky PC; Andersen KG; Robles-Sikisaka R; Grubaugh ND; Aybar A; Nunez MZ; Fermin CD; Garry RF
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-structural protein 1-specific antibodies directed against Zika virus in humans mediate antibody-dependent cellular cytotoxicity.
    Sanchez Vargas LA; Adam A; Masterson M; Smith M; Lyski ZL; Dowd KA; Pierson TC; Messer WB; Currier JR; Mathew A
    Immunology; 2021 Oct; 164(2):386-397. PubMed ID: 34056709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
    Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
    Front Immunol; 2018; 9():597. PubMed ID: 29740424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
    Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
    Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zika Virus-Immune Plasmas from Symptomatic and Asymptomatic Individuals Enhance Zika Pathogenesis in Adult and Pregnant Mice.
    Shim BS; Kwon YC; Ricciardi MJ; Stone M; Otsuka Y; Berri F; Kwal JM; Magnani DM; Jackson CB; Richard AS; Norris P; Busch M; Curry CL; Farzan M; Watkins D; Choe H
    mBio; 2019 Jul; 10(4):. PubMed ID: 31266863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection.
    Stettler K; Beltramello M; Espinosa DA; Graham V; Cassotta A; Bianchi S; Vanzetta F; Minola A; Jaconi S; Mele F; Foglierini M; Pedotti M; Simonelli L; Dowall S; Atkinson B; Percivalle E; Simmons CP; Varani L; Blum J; Baldanti F; Cameroni E; Hewson R; Harris E; Lanzavecchia A; Sallusto F; Corti D
    Science; 2016 Aug; 353(6301):823-6. PubMed ID: 27417494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model.
    Brault AC; Domi A; McDonald EM; Talmi-Frank D; McCurley N; Basu R; Robinson HL; Hellerstein M; Duggal NK; Bowen RA; Guirakhoo F
    Sci Rep; 2017 Nov; 7(1):14769. PubMed ID: 29116169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model.
    Bailey MJ; Duehr J; Dulin H; Broecker F; Brown JA; Arumemi FO; Bermúdez González MC; Leyva-Grado VH; Evans MJ; Simon V; Lim JK; Krammer F; Hai R; Palese P; Tan GS
    Nat Commun; 2018 Nov; 9(1):4560. PubMed ID: 30385750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.